PubMed · 6232307
[Thymoxamine and angle-closure glaucoma].
Abstract
Thymoxamine is a selective alpha sympathetic blocking agent which may be used to stop the mydriasis induces by phenylephrine, ("safe mydriasis"), to differentiate an open but narrow angle glaucoma from an angle closure glaucoma, to treat an acute closure and to induce miosis without shallowing of the anterior chamber before laser trabeculoplasty.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R Etienne. 1983. [Thymoxamine and angle-closure glaucoma].. https://pubmed.health/record/pubmed%3A6232307/thymoxamine-and-angle-closure-glaucoma
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.